期刊文献+

同型半胱氨酸与2型糖尿病血管并发症的关系 被引量:1

Relation between homocysteine and angiopathy in type 2 diabetes mellitus
下载PDF
导出
摘要 目的 :探讨同型半胱氨酸与糖尿病血管并发症的关系。方法 :1 2 4例糖尿病患者分为三组 :单纯糖尿病组、糖尿病微血管病变组和糖尿病大血管病变组 ;正常对照组 30例 ,测定血浆 Hcy,PAI- 1水平及生化指标。结果 :糖尿病大血管病变 Hcy水平明显高于其他三组 ,糖尿病微血管病变组与对照组无显著性差异。结论 :高同型半胱氨酸血症与 2型糖尿病大血管病变的发病有关 ,与微血管病变无相关性 ,需行维生素 B12 、B6 、叶酸等纠正高 Hcy血症。 Objective:To investigate the relatio n between homocysteine(Hcy)and angiopathy in type 2 diabetes mellitus. Methods: 124 NIDDM subjects including simple DM,microangiopathy,macroangiopathy and 30 no rmal subjects were measuried for plasma Hcy,PAI-1,serum biochemical index. Res ults:The patients with macroangiopathy had higher levels and higher prevelance of hyperhomocysteinemia than normal group, while the patients with microangiop athy shoued no significant difference. Conclusions:Fasting homocysteine correla ted with macroangiopathy but not with microangiopathy. VitameB 6, B 12, f olate can correct hyperhomocysteinemia.
出处 《陕西医学杂志》 CAS 北大核心 2005年第3期284-286,共3页 Shaanxi Medical Journal
基金 宁夏回族自治区自然科学基金项目 (A3 0 2 7
关键词 同型半胱氨酸 2型糖尿病 糖尿病血管并发症 对照组 糖尿病大血管病变 糖尿病微血管病变 PAI-1 水平 结论 纠正 Diabetes mellitus Non-insulin-dep endent/complications Vascular disease/etiology Cysteine/analysis
  • 相关文献

参考文献7

  • 1陆元善.同型半胱氨酸代谢和临床应用[J].上海医学检验杂志,2001,16(4):196-198. 被引量:17
  • 2郭清华,张志利,何国芬,闫彩风.IL-4对NOD小鼠1型糖尿病免疫干预及其机制的探讨[J].中国糖尿病杂志,2001,9(2):105-108. 被引量:11
  • 3Scoot CH,Sutton MS. Homocysteine:evidence for a relationship with cardiovascular disease. Cardiology Reviewe,1999;7(2) : 101.
  • 4Okada E, Oida K, Tads H, et al.Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patiens with type2 diabets. Diabetes Care, 1999; 22: 484.
  • 5Agarch CD, Agarch E, AnderssonA, et al. Lakeof association between plasma homocysteine levels and microangiopthy in type 1 dabetes mellitus. Scand J Cline Lab Invest,1994;54 : 637.
  • 6Smulders Y M, Rakie M,Slaats E H, et al. Fasting and post-methionine homocysteine leveles in NIDDM determinants and correlation with retionopathy ,albuminuria, and cardiovaschlar disease. Diabetes Care,1999;22 : 125.
  • 7Scheider DJ , Nordt TK, Sobel BE. Attenuated fibrinolysis and accelerate atherogenesis in type 2diabetes patients. Dibetes , 1994; 42: 1.

二级参考文献17

  • 1龚非力 龙振洲.免疫细胞(二).医学免疫学(第2版)[M].人民卫生出版社,1996.89.
  • 2[1]Finkelstein JD, Martin JJ. Related Papers:molecules in focus: Homocysteine [J]. IJBCB, 2000,32(4):385-389.
  • 3[2]Warren CJ. What is homocysteine? Am J Nurs, 1999,99(10):34-41.
  • 4[3]Langman LJ, Cole DEC. Homocysteine: cholesterol of the 90s'[J]. C C A, 1999,286(1~2):63-80.
  • 5[4]Ueland PM, Refsum H, Stabler SP et al. Total homocysteine in plasma or serum:methods and clinical applications [J]. Clin Chem, 1993,39(9):1764-1779.
  • 6[5]Amores-Sanchez MI, Medina MA. Methods for the determination of plasma total homocysteine [J]. Clin Chem Lab Med 2000,38(3):199-204.
  • 7[6]Thambyrajah J, Townend JN. Homocysteine and atherothrombosis-mechanismsfor injury [J]. Eur Heart J, 2000,21(12):967-974.
  • 8[7]Graham IM, Daly LE, Refsum H, et al. Plasma homocysteine as a risk factor for vascular disease [J], JAMA, 1997,277(22):1775-1781.
  • 9[8]Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men [J]. Lancet, 1995,346(8987):1395-1398.
  • 10[9]Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentration and extracranial carotid-artery stenosis [J]. N Engl J Med, 1995,332(5):286-291.

共引文献26

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部